Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme

References

• McLendon R, Halperin E. Is the long-term survival of patients with intracranial glioblastoma multiforme overstated? Cancer98, 1745–1748 (2003).
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason W, van den Bent M et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med.352, 987–996 (2005).
   PubMed Web of Science ®Google Scholar
• Surawicz T, Davis F, Freels S, Laws ER Jr, Menck HR. Brain tumor survival: results from the national cancer data base. J. Neurooncol.40, 151–160 (1998).
   PubMed Web of Science ®Google Scholar
• Tait M, Petrik V, Loosemore A, Bell BA, Papadopoabs MC. Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases. Br. J. Neurosurg.21, 496–500 (2007).
   PubMed Web of Science ®Google Scholar
• Curran WJ Jr, Scott CB, Horton J et al. Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J. Natl Cancer Inst.85, 704–710 (1993).
   PubMed Web of Science ®Google Scholar
• Wrensch M, Minn Y, Chew T et al. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol.4, 278–299 (2002).
   PubMed Web of Science ®Google Scholar
• Hess K, Broglio K, Bondy M. Adult glioma incidence trends in the United States, 1977–2000. Cancer101, 2293–2299 (2002).
   Web of Science ®Google Scholar
• Combs SE, Wagner J, Bischof M et al. Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. Int. J. Radiat. Oncol. Biol. Phys.70, 987–992 (2008)
   PubMed Web of Science ®Google Scholar
• Sijben AE, McIntyre JB, Roldán GB et al. Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme. J. Neurooncol.89, 97–103 (2008)
   PubMed Web of Science ®Google Scholar
• Minniti G, Sanctis V, Muni R et al. Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma. J. Neurooncol.91, 95–100 (2009).
   PubMed Web of Science ®Google Scholar
• Clark J, Chang, E, Levin V et al. Optimizing radiotherapy schedules for elderly glioblastoma multiforme patients. Expert Rev. Anticancer Ther.8(5), 733–741 (2008).
   PubMed Web of Science ®Google Scholar
• Chang E, Yi W, Allen P et al. Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors. Int. J. Radiat. Oncol. Biol. Phys.56(2), 519–528 (2003).
   PubMed Web of Science ®Google Scholar
• Mohan D, Suh J, Phan J et al. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int. J. Radiat. Oncol. Biol. Phys.42, 981–987 (1998).
   PubMed Web of Science ®Google Scholar
• Kirkbride P, Tannock IF. Trials in palliative treatment – have the goal posts been moved? Lancet Oncol.9, 186–187 (2008).
   PubMed Web of Science ®Google Scholar
• Mauer ME, Bottomley A, Collette L, Slotman BJ. Palliative-care trials: how best to publish findings? Lancet Oncol.9, 411–412 (2008).
   PubMed Web of Science ®Google Scholar
• Wong J, Hird A, Kirou-Mauro A et al. Quality of life in brain metastases radiation trials: a literature review. Curr. Oncol.15, 25–45 (2008).
   PubMed Web of Science ®Google Scholar
• Weitzner M, Meyers C, Gelke C et al. The functional assessment of cancer therapy (FACT) scale: development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumours. Cancer75, 1151–1161 (1995).
   PubMed Web of Science ®Google Scholar
• Hutchins L, Unger J, Crowley J et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N. Engl. J. Med.341, 2061–2067 (1999).
   PubMed Web of Science ®Google Scholar
• Lewis J, Kilgore M, Goldman D et al. Participation of patients 65 years of age or older in cancer clinical trials. J. Clin. Oncol.21, 1383–1389 (2003).
   PubMed Web of Science ®Google Scholar
• Iwamoto F, Reiner A, Panageas K et al. Patterns of care in elderly glioblastoma patients. Ann. Neurol.64, 628–634 (2008).
   PubMed Web of Science ®Google Scholar
• Villa S, Vinolas N, Verger E et al. Efficacy of radiotherapy for malignant gliomas in elderly patients. Int. J. Radiat. Oncol. Biol. Phys.42(5), 977–980 (1998).
   PubMed Web of Science ®Google Scholar
• McAleese J, Stenning S, Ashley S et al. Hypofractionated radiotherapy for poor prognosis malignant glioma: matched pair survival analysis with MRC controls. Radiother. Oncol.67, 177–182 (2003).
   PubMed Web of Science ®Google Scholar
• Keime-Guibert F, Chinot O, Taillandier L et al. Radiotherapy for glioblastoma in the elderly. N. Engl. J. Med.356, 1527–1537 (2007).
   PubMed Web of Science ®Google Scholar
• Roa W, Brasher P, Bauman G et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J. Clin. Oncol.22, 1583–1588 (2004).
   PubMed Web of Science ®Google Scholar
• Lutterbach J, Ostertag C. What is the appropriate radiotherapy protocol for older patients with newly diagnosed glioblastoma? J. Clin. Oncol.23, 2869–2870 (2005).
   PubMed Web of Science ®Google Scholar
• Hulshof M, Schimmel E, Andries Bosch D et al. Hypofractionation in glioblastoma multiforme. Radiother. Oncol.54, 143–148 (2000).
   PubMed Web of Science ®Google Scholar
• Chinot O, Barrie M, Frauger E et al. Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly population. Cancer100, 2208–2214 (2004).
   PubMed Web of Science ®Google Scholar
• Glantz M, Chamberlain M, Liu Q et al. Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas. Cancer97(9), 2262–2266 (2003).
   PubMed Web of Science ®Google Scholar
• Brandes A, Vastola F, Basso U et al. A prospective study on glioblastoma in the elderly. Cancer97, 657–662 (2003).
   PubMed Web of Science ®Google Scholar
• Brandes A, Franceschi E, Tosoni A et al. Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. Cancer115, 3512–3518 (2009).
   PubMed Web of Science ®Google Scholar
• Jones B, Sanghera P. Estimation of radiobiologic parameters and equivalent radiation dose of cytotoxic chemotherapy in malignant glioma. Int. J. Radiat. Oncol. Biol. Phys.68, 441–448 (2007).
   PubMed Web of Science ®Google Scholar
• Jones S. Cancer in the developing world: a call to action. BMJ319, 505–508 (1999).
   PubMed Web of Science ®Google Scholar
• Van Der Giessen P, Alert J, Badri C et al. Multinational assessment of some operational costs of teletherapy. Radiother. Oncol.71, 347–355 (2004).
   PubMed Web of Science ®Google Scholar
• Levin C, El Gueddari B, Meghzifene A. Radiation therapy in Africa: distribution and equipment. Radiother. Oncol.52, 79–84 (1999).
   PubMed Web of Science ®Google Scholar
• Barton M, Frommer M, Shafiq J. Role of radiotherapy in cancer control in low-income and middle-income countries. Lancet Oncol.7, 584–595 (2006).
   PubMed Web of Science ®Google Scholar
• Zubizarreta E, Poitevin A, Levin C. Overview of radiotherapy resources in Latin America: a survey by the international atomic energy agency (IAEA). Radiother. Oncol.73, 97–100 (2004).
   PubMed Web of Science ®Google Scholar
• Tatsuzaki H, Levin C. Quantitative status of resources for radiation therapy in Asia and Pacific region. Radiother. Oncol.60, 81–89 (2001).
   PubMed Web of Science ®Google Scholar
• Hoegler D, Davey P. A prospective study of short course radiotherapy in elderly patients with malignant glioma. J. Neurooncol.33, 201–204 (1997).
   PubMed Web of Science ®Google Scholar
• Newall J, Ransohoff J, Kaplan B. Glioblastoma in the older patient: how long a course of radiotherapy is necessary? J. Neurooncol.6, 325–327 (1988).
   PubMed Web of Science ®Google Scholar
• Slotman B, Kralendonk J, van Alphen H et al. Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors. Int. J. Radiat. Oncol. Biol. Phys.34, 895–898 (1996).
   PubMed Web of Science ®Google Scholar
• Jeremic B, Shibamoto Y, Grujicic D et al. Short-course radiotherapy in elderly and frail patients with glioblastoma multiforme. A Phase II study. J. Neurooncol.44, 85–90 (1999).
   PubMed Web of Science ®Google Scholar
• Idbaih A, Taillibert S, Simon J et al. Short course of radiation therapy in elderly patients with glioblastoma multiforme. Cancer Radiother.12, 788–792 (2008).
   PubMed Web of Science ®Google Scholar
• Ford J, Stenning S, Boote D et al. A short fractionation radiotherapy treatment for poor prognosis patients with high grade glioma. Clin. Oncol. (R. Coll. Radiol.)9, 20–24 (1997).
   PubMedGoogle Scholar
• Bauman G, Gaspar L, Fisher B et al. A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys.29, 835–839 (1994).
   PubMed Web of Science ®Google Scholar